IRIS PubliCatt

Pinto, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.112
NA - Nord America 4.198
AS - Asia 1.280
AF - Africa 48
SA - Sud America 37
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 5
Totale 20.695
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 10.432
US - Stati Uniti d'America 4.125
DE - Germania 1.774
SE - Svezia 759
CN - Cina 540
UA - Ucraina 458
FR - Francia 375
SG - Singapore 309
PL - Polonia 258
GB - Regno Unito 240
NL - Olanda 198
IE - Irlanda 175
IN - India 153
ID - Indonesia 115
RU - Federazione Russa 100
FI - Finlandia 89
CH - Svizzera 71
CA - Canada 58
BE - Belgio 56
JP - Giappone 49
TR - Turchia 48
ES - Italia 31
CI - Costa d'Avorio 21
BR - Brasile 19
IR - Iran 18
MA - Marocco 16
RO - Romania 14
AT - Austria 12
CZ - Repubblica Ceca 12
EU - Europa 11
AR - Argentina 8
BZ - Belize 8
HK - Hong Kong 8
HU - Ungheria 7
KR - Corea 7
CO - Colombia 6
GR - Grecia 6
LT - Lituania 6
MX - Messico 6
SM - San Marino 5
TH - Thailandia 5
TW - Taiwan 5
AL - Albania 4
AU - Australia 4
BG - Bulgaria 4
VN - Vietnam 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EC - Ecuador 3
IS - Islanda 3
MY - Malesia 3
PH - Filippine 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
CV - Capo Verde 2
DK - Danimarca 2
EG - Egitto 2
HR - Croazia 2
KH - Cambogia 2
LU - Lussemburgo 2
MT - Malta 2
NO - Norvegia 2
PK - Pakistan 2
UG - Uganda 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CL - Cile 1
CM - Camerun 1
EE - Estonia 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MC - Monaco 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 20.695
Salva come PNG Salva come JPEG
Città #
Milan 1.084
Chandler 903
Rome 879
Ashburn 311
Naples 271
Singapore 246
Jacksonville 244
San Mateo 191
Florence 188
Turin 188
Warsaw 181
Ann Arbor 176
Dublin 168
Bologna 150
Wilmington 141
Palermo 140
Nanjing 125
Nürnberg 107
Bari 106
Jakarta 106
Dearborn 103
Genoa 102
Houston 101
Woodbridge 94
Catania 91
Los Angeles 80
Verona 80
Fairfield 77
Nanchang 75
Bremen 69
Munich 69
Lawrence 62
Kraków 60
Boston 58
Redwood City 53
New York 52
Cattolica 50
Moscow 50
Brescia 49
Seattle 48
Beijing 47
Padova 46
Brussels 44
Venice 44
Ottawa 41
Princeton 41
Chicago 40
Marseille 37
Parma 34
Lancaster 33
Livorno 32
Mountain View 32
Perugia 32
Cagliari 31
Messina 31
Redmond 30
Salerno 30
Bergamo 29
Falls Church 29
Izmir 29
Kadoma 28
Reggio Emilia 28
Kunming 27
Pescara 27
Trieste 26
Cambridge 25
Taranto 25
San Jose 24
Tianjin 24
Modena 22
Abidjan 21
Augusta 21
Lucca 21
Paris 20
University Park 20
Hebei 19
Helsinki 19
Caserta 18
Enterprise 18
Hangzhou 18
Novara 18
Shenyang 18
Jiaxing 17
Monza 17
Boardman 16
Macerata 16
Rimini 16
Lecce 15
Udine 15
Changsha 14
Leawood 14
London 14
Norwalk 14
Pisa 14
Amsterdam 13
Sesto Fiorentino 13
Zurich 13
Andover 12
Cesano Maderno 12
Changchun 12
Totale 8.784
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 7.995
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.007
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 754
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 733
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 439
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 335
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 302
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 300
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 255
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 254
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 253
Pros-IT CNR: an Italian prostate cancer monitoring project 220
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 192
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 178
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 177
Le infezioni delle vie urinarie 172
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 169
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 165
URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY 153
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 152
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 144
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 144
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 133
The occult urothelial cancer 129
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 126
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 126
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 123
[Overactive bladder syndrome: the social and economic perspective] 122
Male infertility: non-surgical therapy 121
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 121
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 120
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 119
Imaging in prostate cancer diagnosis: present role and future perspectives 117
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 117
Human factors in surgery: from Three Mile Island to the operating room 114
Advanced bladder cancer: New agents and new approaches. A review 114
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 114
Bladder and prostate metastasis from small cell lung cancer: a rare entity 114
Metabolic reprogramming by malat1 depletion in prostate cancer 114
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 113
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 112
Brachytherapy in men with prostate cancer: update on indications and outcomes 112
Hot topics in urological health economics. A mini review 111
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 108
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 108
Imaging in prostate cancer staging: present role e future perspectives 108
Size of Bladder Cancers: Correlation among Different Types of Measurement 105
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 104
Imaging of renal cell carcinoma: state of the art and recent advances 102
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 102
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 100
Advanced bladder cancer: New agents and new approaches. A review 99
Imaging in prostate cancer staging: present role and future perspectives 98
Inhibition of prostate efferent neurotransmission by amikacin 95
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 92
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 91
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 90
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 89
Therapeutic strategies in penile cancer: state of the art 89
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 88
The occult urothelial cancer 88
Circumcision: history, religion and law 87
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 87
Local relapse of prostate cancer after primary definitive treatment: the management 86
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 84
Imaging of renal cell carcinoma: state of the art and recent advances 84
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 82
Imaging in prostate cancer diagnosis: present role and future perspectives 80
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 79
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 78
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 77
Anti-anginal drugs: Systematic review and clinical implications 73
A circulating miRNA assay as a first-line test for prostate cancer screening 71
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 71
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 67
A circulating miRNA assay as a first-line test for prostate cancer screening 64
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 63
Imaging of renal cell carcinoma: state of the art and recent advances. 61
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 60
Shock-wave lithotripsy or ureterorenoscopy for renal stones? 55
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 52
Immediate ileal ureter replacement for ureteral avulsion during ureterescopy 50
Anti-Anginal drugs-beliefs and evidence: Systematic review covering 50 years of medical treatment 48
The cost of treatment and follow-up of bladder cancer in Italy 47
[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives] 45
Sports and Genitourinary Traumas 43
[Continuing evolution of statistical tests in medical research] 37
[Prostatitis syndromes and sporting activities] 37
[Sport, infertility and erectile dysfunction] 37
[Doping and urologic tumors] 35
Clinical and pathological characteristics of patients presenting with biochemical progression after radical retropubic prostatectomy for pathologically organ-confined prostate cancer 30
Familial and hereditary prostate cancer by definition in an Italian surgical series: Clinical features and outcome 30
Bladder tumor markers: A review of the literature 30
null 26
Circumcision: history, religion and law 20
Markers for Urological Malignancies 18
Imaging in bladder cancer: Present role and future perspectives 18
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 16
Disseminated intravascular coagulation secondary to metastatic prostate cancer: Case report and review of the literature 15
Finding of no tumor (pT0) in patients undergoing radical retropubic prostatectomy for clinically localized prostate cancer 14
Totale 20.798
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.671
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020969 0 0 0 0 0 132 152 90 184 78 201 132
2020/20211.333 66 126 68 115 199 79 140 57 142 82 187 72
2021/20221.420 126 90 62 118 110 77 66 181 102 102 174 212
2022/20233.917 359 341 263 458 185 405 173 315 427 255 416 320
2023/20245.898 321 532 389 460 453 449 479 587 430 582 559 657
2024/20253.898 596 683 719 649 777 474 0 0 0 0 0 0
Totale 20.870